Species : |
Human |
Source : |
BHK |
Tag : |
Non |
Description : |
This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Alternative splicing of this gene results in 2 transcripts. Defects in this gene can cause coagulopathy. |
Physical Appearance : |
Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation : |
The protein 1mg/ml was lyophilized after from a sterile solution containing 4.86mg sodium chloride, 2.45mg calcium chloride dihydrate, 50mg mannitol and 116µg Tween 80. |
Purity : |
Greater than 98.0% as determined by: (a) Analysis by RP-HPLC. (b) Anion-exchange FPLC. (c) Analysis by reducing and non-reducing SDS-PAGE Silver Stained. |
Dimers And Aggregates : |
Less than 1% as determined by silver stained SDS-PAGE gel analysis. |
Biological Activity : |
The rHuFactor VIIa is fully biologically active when compared to standard. The potency per mg was tested and found to be 50,000Units/mg. |
Endotoxin : |
Less than 0.1 ng/µg (IEU/µg) of rHuFactor-VIIa. |
Solubility : |
It is recommended to reconstitute the lyophilized rHuFactor-VIIa in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions. |
Stability : |
Lyophilized rHuFactor-VIIa although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution rHuFactor-VIIa should be stored at 4°Cbetween 2-7 days and for future use below -18°C. Please prevent freeze-thaw cycles. |